TXG
10X Genomics Inc
NASDAQ: TXG · HEALTHCARE · HEALTH INFORMATION SERVICES
$22.05
+9.16% today
Updated 2026-04-30
Market cap
$2.61B
P/E ratio
—
P/S ratio
4.05x
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$8 – $26
Volume
2.4M
10X Genomics Inc (TXG) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $75.61M | $124.31M | $605.92M | $929.34M | $1.02B | $1.03B | $965.14M | $918.64M |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Current assets | $68.11M | $106.24M | $480.84M | $774.37M | $747.59M | $635.03M | $596.02M | $584.39M |
| Total liabilities | $188.12M | $344.30M | $185.84M | $190.27M | $201.26M | $223.24M | $224.10M | $208.50M |
| Current liabilities | $22.14M | $32.36M | $63.05M | $118.13M | $110.36M | $130.96M | $127.16M | $117.63M |
| Long-term debt | $6.33M | $25.49M | $19.84M | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — |
| Retained earnings | $-118.63M | $-231.12M | $-262.37M | $-805.10M | $-863.32M | $-1.03B | $-1.28B | $-1.47B |
| Accounts receivable | $13.34M | $28.09M | $33.37M | $51.21M | $85.25M | $104.21M | $114.83M | $87.86M |
| Inventory | $4.84M | $8.57M | $15.27M | $29.96M | $59.97M | $81.63M | $73.71M | $83.11M |
| Goodwill | $0.00 | $0.00 | — | $0.00 | $4.51M | $4.51M | $4.51M | $4.51M |